The Medicines and Healthcare products Regulatory Agency (MHRA) would like to make everyone aware of a medicines notification issued by the marketing authorisation holder (MAH) Doncaster Pharma Ltd about Keppra 500mg film-coated tablets.

They have identified an error relating to the Braille printed on the cartons on the parallel imported packs which have been repackaged by BModesto B.V.

 Please see the list of affected products in the medicines notification.

Approximately 70% of the packs across the listed batches have been repackaged with the Braille message on the Keppra 500mg film-coated tablets incorrectly stating strength as 1000mg. 

There is no issue with the quality of the tablets, therefore, the affected batches are not being recalled.

Further information and actions for healthcare professionals and patients can be found in the medicines notification.

If you have any queries, please see the contact information on the notification or email info@mhra.gov.uk.